An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines: evidence from 35 countries

Kanavos, Panos ORCID: 0000-0001-9518-3089, Leon, Giovanny, Carbonel, Christophe, Rampuria, Aparajit, Singh Rajpoot, Ravindra and Joshi, Parth (2024) An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines: evidence from 35 countries. European Journal of Health Economics. ISSN 1618-7598

Text (s10198-024-01706-x) - Published Version Available under License Creative Commons Attribution. Download (2MB)

• Author
• Scopus publication

Abstract

This paper analyses the structure of and variability in taxation and prescription drug distribution policies and quantifies the impact of such policies on the cost of prescription drugs to health systems in 35 countries. Taxes on prescription drugs remain highly prevalent (83% of the sample) although 63% of the sample countries implement a lower than standard VAT rate. Three remuneration types of the wholesale and retail distribution chain have been identified. Wholesale and retail distributors are remunerated on a regressive mark-up basis, which is price-dependent, although fixed fees and fixed percentages, which are non-price dependent, are also highly prevalent. Price component analysis for three groups of products classed as high-, medium- and low-priced suggests that mark-ups plus taxes varied significantly across countries and products, and ranged from 5% to 187% of ex-factory prices. Average margins also vary significantly by countries and products ranging 5–65% of retail prices. The cost of distribution and taxation contributes significantly to prescription drug costs for health systems. Although distribution chain remuneration raises efficiency and overall affordability questions, these need to be considered together with the regulatory framework shaping market structure of the distribution chain, as well as any prevailing horizontal and vertical integration policies. The overall cost of prescription drugs could be reduced immediately by eliminating taxation; this could go some way to alleviate fiscal pressures on health budgets, whilst avoiding resource re-allocation from health to other sectors.

Item Type:	Article
Official URL:	https://link.springer.com/journal/10198
Additional Information:	© 2024 The Author(s)
Divisions:	Health Policy
Subjects:	R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine H Social Sciences > HB Economic Theory
Date Deposited:	12 Jul 2024 16:36
Last Modified:	12 Dec 2024 04:22
URI:	http://eprints.lse.ac.uk/id/eprint/124243

Actions (login required)

View Item